Aevi Genomic Medicine (GNMX) - 7 Year Stock Split History

Historical stock splits for Aevi Genomic Medicine since 2011. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Aevi Genomic Medicine Annual Stock Splits
Aevi Genomic Medicine Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.058B $0.000B
Aevi Genomic Medicine Inc. is focused on genomic medicine. The Company focuses on translating genetic discoveries into novel therapies. Its product candidates include AEVI-001 and AEVI-002 which are in clinical trial stage. Aevi Genomic Medicine Inc., formerly known as Medgenics Inc., is based in WAYNE, United States.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $62.549B 10.73
Teva Pharmaceutical Industries (TEVA) Israel $22.320B 6.24
Mylan (MYL) United Kingdom $19.354B 8.23
Bausch Health Cos (BHC) Canada $7.455B 5.57
Dr Reddy's Laboratories (RDY) India $5.335B 23.83
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.637B 4.48
Akorn (AKRX) United States $2.348B 11.63
Supernus Pharmaceuticals (SUPN) United States $2.271B 24.30
Assembly Biosciences (ASMB) United States $1.006B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.816B 117.53
CymaBay Therapeutics (CBAY) United States $0.718B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.637B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.613B 0.00
Homology Medicines (FIXX) United States $0.587B 0.00
Voyager Therapeutics (VYGR) United States $0.574B 0.00
Corium (CORI) United States $0.336B 0.00
Teligent (TLGT) United States $0.223B 0.00
Sol-Gel Technologies (SLGL) Israel $0.119B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.116B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.077B 0.00
Versartis (VSAR) United States $0.060B 0.00
Evoke Pharma (EVOK) United States $0.040B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.022B 0.00
Acasti Pharma (ACST) Canada $0.017B 0.00
China Pharma Holdings (CPHI) China $0.010B 0.00
Agile Therapeutics (AGRX) United States $0.009B 0.00